▲Wirig Diagram Hot
▲ ▲ ▼

Papillary Renal Cell Carcinoma with Reverse Polarity: Pathology Highlights

By

Papillary renal cell carcinoma (PRCC) is a type of kidney cancer that begins in the lining of the renal tubules, which filter waste from the blood to produce urine. One of its unique pathological features is 'reverse polarity', where the cancer cells face the wrong direction, towards the glomerulus instead of the urinary space. This article explores the pathology outlines of papillary renal cell carcinoma with reverse polarity.

Understanding PRCC with reverse polarity is crucial for accurate diagnosis and effective treatment planning. This subtype accounts for around 10-15% of all papillary renal cell carcinomas and has distinct characteristics that set it apart from other types of kidney cancer.

Pathological Features of PRCC

Papillary renal cell carcinoma typically appears as a solid or cystic mass with papillary structures. It often exhibits a 'chicken wire' pattern on microscopic examination, characterized by a delicate vascular network supporting small papillae.

an image of some pink cells
an image of some pink cells
Malignant Tumors of the Kidney
Malignant Tumors of the Kidney
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population - Nature Communications
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population - Nature Communications

Histologically, these tumors are composed of cuboidal, Columnar or hobnail cells that line the papillary cores. However, in reverse polarity PRCC, these cells face the opposite direction, towards the glomerulus.

Reverse Polarity in PRCC

In reverse polarity PRCC, the cuboidal or hobnail cells lining the papillae face the glomerulus instead of the urinary space. This reverses the typical polarity seen in normal renal tubules and other subtypes of PRCC. This unique feature was first described by Delahunta et al. and is now recognized as a distinct variation of this cancer.

Impairment of MAD2B–PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas | PNAS
Impairment of MAD2B–PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas | PNAS
an x - ray shows the location of the diaper in the lower part of the abdomen
an x - ray shows the location of the diaper in the lower part of the abdomen
Chromophobe
Chromophobe

Immunohistochemical markers like AMACR and CK7 can help confirm this diagnosis, as they often stain positive in reverse polarity PRCC. At the same time, markers like CD10 and CAIX may show reduced or reversed expression compared to other PRCC subtypes.

Clinical Implications of Reverse Polarity in PRCC

The presence of reverse polarity in PRCC has clinical implications for diagnosis and treatment. The reversed polarity can cause confusion with other renal tumors, such as chromophobe renal cell carcinoma or oncocytoma. Therefore, accurate recognition of this feature is vital for avoiding misdiagnosis.

The impact of reverse polarity on the prognosis and behavior of PRCC is not yet fully understood. Some studies suggest that reverse polarity PRCC may have a more aggressive behavior and a worse prognosis than typical PRCC. However, further research is needed to confirm these findings and guide clinical decision-making.

BBOX1 restrains TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma - Nature Communications
BBOX1 restrains TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma - Nature Communications
Papillary Left Renal Cell Carcinoma
Papillary Left Renal Cell Carcinoma
Renal cell carcinoma - Nature Reviews Disease Primers
Renal cell carcinoma - Nature Reviews Disease Primers
Inherited susceptibility to uterine leiomyomas and renal cell cancer | PNAS
Inherited susceptibility to uterine leiomyomas and renal cell cancer | PNAS
Transitional Cell Carcinoma Distal Left Renal Ureter
Transitional Cell Carcinoma Distal Left Renal Ureter
Figure 4A
Figure 4A

Diagnosis and Differential Diagnosis

Histopathology is crucial for diagnosing PRCC, with reverse polarity being a key feature in some subtypes. However, it's essential to consider other renal tumors in the differential diagnosis, especially those with reverse polarity features. Immunohistochemical stains can help differentiate between these entities.

The role of molecular pathology in the diagnosis of PRCC is an emerging area. Next-generation sequencing and other molecular techniques may help identify specific genetic alterations in PRCC, including those associated with reverse polarity, paving the way for more personalized treatments.

As our understanding of reverse polarity papillary renal cell carcinoma continues to evolve, it is clear that recognizing this pathological feature is vital for accurate diagnosis and appropriate treatment. Further research is needed to fully understand the clinical significance of reverse polarity and optimize patient care. If you or a loved one has been diagnosed with kidney cancer, it is essential to work with a healthcare team experienced in treating this complex disease.

Immunotherapy resistance in kidney cancer driven by myeloid cell signaling
Immunotherapy resistance in kidney cancer driven by myeloid cell signaling
Variants of Papillary Thyroid Carcinoma (Microcarcinoma, Tall Cell, Columnar, Follicular)
Variants of Papillary Thyroid Carcinoma (Microcarcinoma, Tall Cell, Columnar, Follicular)
💬 Comments ↗ Share ★ Save
AD